Patent protection for semaglutide, the active ingredient in Danish drugmaker Novo Nordisk's diabetes drug Ozempic and ...
Dr Reddy’s Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name ...
Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as ...
Dr Reddy's Laboratories is poised to launch its generic semaglutide injection, potentially named Obeda, in India by March.
10don MSN
Indian drugmaker Dr Reddy's gearing up for March debut of generic semaglutide Obeda, sources say
By Rishika Sadam MUMBAI, Feb 25 (Reuters) - Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according ...
PHINIA, under its brand Delphi, said it will build on its multi-year partnership with BWT Alpine Formula One Team as the ...
Welcome back to theFashionSpot’s Top Picks shopping series, where we shine a spotlight upon the collections of just about ...
Mumbai: Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with ...
Gear Patrol on MSN
This Underrated Everyday Tool Watch Finally Hits Its Stride
Time to add one to your wishlist.
Feb 26 () - Eli Lilly on Thursday released new data from a head-to-head trial of its experimental weight-loss pill, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results